LifeSci

ProciseDx

ProciseDx provides point-of-care testing that delivers precise, high-quality results—empowering physicians and patients

ProciseDx in the News

ProciseDx has secured a $10.5M Series A to continue funding development and commercialization of its point-of-care diagnostic platform

July 21, 2020

ProciseDx Files 510k and Prepares for EU launch of Novel Point of Care Technology

May 12, 2020

Share on Facebook

Tweet about this on Twitter

Share on LinkedIn

Email this to someone

OTHER COMPANIES

Truvian

takelessons

tealium

Back to All Companies